International Vaccine Institute

This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (June 2018) (Learn how and when to remove this message)

International Vaccine Institute

Abbreviation	IVI
Formation	October 9, 1997
Founder	United Nations Development Programme
Type	International organization
Purpose	Discover, develop, and deliver safe, effective, and affordable vaccines for global public health.
Headquarters	Seoul, Republic of Korea
Membership	39 member states and the World Health Organization
Director General	Jerome Kim, M.D.
Budget	US$27 million(2017)[1]
Staff	210
Website	www.ivi.int

The International Vaccine Institute (IVI) is a non-profit, autonomous international organization established with the mandate of making vaccines available to all. Collaborating closely with the global scientific community, public health entities, governments, and industry stakeholders, IVI focuses on vaccine research and deployment. This includes conducting new vaccine designs in laboratories, advancing vaccine development and assessment in real-world settings, and facilitating the sustainable integration of vaccines in regions where they are most urgently required.

Initially conceived as an initiative under the auspices of the United Nations Development Program (UNDP), IVI transitioned into a fully-independent international entity in 1997, with its headquarters situated in Seoul, Republic of Korea. IVI currently has a membership comprising 39 states, with 33 signatories and 23 parties, alongside the endorsement of the World Health Organization (WHO) through its Establishment Agreement. Distinctively, IVI is mandated to concentrate exclusively on vaccine research and deployment tailored to populations in developing areas, with particular emphasis on combating diseases with a serious impact on public health in these regions.^[2]